References
Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e278S–e313S.
Deng HY, Qin CL, Li G, et al. Can lobe-specific lymph node dissection be an alternative to systematic lymph node dissection in treating early-stage non-small cell lung cancer: a comprehensive systematic review and meta-analysis? J Thorac Dis. 2018;10(5):2857–2865.
Han H, Chen H. Selective lymph node dissection in early-stage non-small cell lung cancer. J Thorac Dis. 2017;9(7):2102–2107.
Deng HY, Zhou J, Wang RL, et al. Lobe-specific lymph node dissection for clinical early-stage (cIA) peripheral non-small cell lung cancer patients: what and how? Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-019-07926-3.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Han-Yu Deng and Qinghua Zhou report no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This ASO Author Reflections is a brief invited commentary on the article, “Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-small Cell Lung Cancer Patients: What and How?” Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-019-07926-3.
Rights and permissions
About this article
Cite this article
Deng, HY., Zhou, Q. ASO Author Reflections: Lobe-Specific Lymph Node Dissection for Early-Stage Non-small Cell Lung Cancer: A Long Way to Go in the Era of Minimally Invasive Thoracic Surgery. Ann Surg Oncol 27, 470–471 (2020). https://doi.org/10.1245/s10434-019-07946-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-019-07946-z